Dr Thurn for Stockhead on activities to lift the FDA clinical hold on NUZ-001LikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be sent privately to Neurizon. The company may choose to make this question public.Start the conversationAsk Neurizon a question about this update.Discover
